Tonix Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference
Feb 02, 2016 12:05 pm UTC| Business
NEW YORK, Feb. 02, 2016 -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), which is developing next-generation medicines for fibromyalgia, post-traumatic stress disorder (PTSD), and episodic tension-type...
ADT Reports First Quarter Fiscal 2016 Results
Feb 02, 2016 12:03 pm UTC| Business
Continued execution drives increases in revenue and EBITDA before special items, and improvements in key operating metrics Announces launch of ADT Canopy and All-In-One Smart Security product; initiated eight...
McEwen Mining Regains Compliance With NYSE Listing Standards
Feb 02, 2016 12:01 pm UTC| Business
TORONTO, Feb. 02, 2016 -- McEwen Mining Inc. (NYSE:MUX) (TSX:MUX) is pleased to announce receipt of notification from the New York Stock Exchange (the “NYSE”) that it has regained compliance with the NYSE’s continued...
iKang Announces Equity Investment in New China Life Insurance Health Investment Management Co., Ltd.
Feb 02, 2016 12:00 pm UTC| Business
BEIJING, Feb. 02, 2016 -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq:KANG), China’s largest private preventive healthcare services provider, today announced that it has completed a strategic...
DSP Group, Inc. Reports Fourth Quarter 2015 Results
Feb 02, 2016 12:00 pm UTC| Business
Record Quarterly Contribution from New Products at 33% of RevenuesFourth Quarter Gross Margin Increased 340 Basis Points Year-over-Year to 43%Fourth Quarter GAAP and Non-GAAP Earnings per Share Exceeded Guidance LOS...
Dates and Locations Announced for Cloudera Sessions 2016
Feb 02, 2016 12:00 pm UTC| Business
Palo Alto, CA, Feb. 02, 2016 -- What: Today Cloudera, the global provider of the fastest, easiest, and most secure data management and analytics platform built on Apache Hadoop and the latest open source...
NewLink Genetics Corporation Announces Project to Develop New Treatment Options for the Zika Virus
Feb 02, 2016 12:00 pm UTC| Business
AMES, Iowa, Feb. 02, 2016 -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company at the forefront of discovering, developing and commercializing novel immuno-oncology product candidates, including...